Hepatitis C virus and risk of non-Hodgkin lymphoma in British Columbia, Canada

International Journal of Cancer

Volumn 122, Issue 3, 2008, Pages 630-633

  Spinelli, John J ^a   Lai, Agnes S ^a   Krajden, Mel ^b   Andonov, Anton ^c   Gascoyne, Randy D ^a   Connors, Joseph M ^a   Brooks Wilson, Angela R ^a   Gallagher, Richard P ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

Epidemiology; Etiology; Hepatitis; Hepatitis C; Non Hodgkin lymphoma; Virus

Indexed keywords

HEPATITIS C ANTIBODY;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANADA; CANCER REGISTRY; CANCER RISK; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MARGINAL ZONE LYMPHOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

ADULT; AGED; ANTIBODIES, VIRAL; CANADA; CASE-CONTROL STUDIES; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHOMA, NON-HODGKIN; MIDDLE AGED; ODDS RATIO; RISK FACTORS;

EID: 37349015581     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23105     Document Type: Article

References (30)

1. Ries L, Harkins D, Krapcho M, Mariotto A, Miller B, Feuer E, Clegg L, Eisner M, Horner M, Howlader N, Hayat M, Hankey B, et al. SEER cancer statistics review, 1975-2003, vol. 2006 Bethesda, MD: National Cancer Institute, 2005.
2. Sandin S, Hjalgrim H, Glimelius B, Rostgaard K, Pukkala E, Askling J. Incidence of non-Hodgkin's lymphoma in Sweden, Denmark, and Finland from 1960 through 2003: an epidemic that was. Cancer Epidemiol Biomarkers Prev 2006;15:1295-300.
3. Kayali Z, Buckwold VE, Zimmerman B, Schmidt WN. Hepatitis C, cryoglobulinemia, and cirrhosis: a meta-analysis. Hepatology 2002;36:978-85.
4. Ferri C, La Civita L, Longombardo G, Zignego AL, Pasero G. Mixed cryoglobulinaemia: a cross-road between autoimmune and lymphoproliferative disorders. Lupus 1998;7:275-9.
5. Ramos-Casals M, Trejo O, Garcia-Carrasco M, Cervera R, Font J. Mixed cryoglobulinemia: new concepts. Lupus 2000;9:83-91.
6. Ferri C, Monti M, La Civita L, Longombardo G, Greco F, Pasero G, Gentilini P, Bombardieri S, Zignego AL. Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood 1993;82:3701-4.
7. Dal Maso L, Franceschi S. Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies. Cancer Epidemiol Biomarkers Prev 2006;15:2078-85.
8. Purcell RH. The discovery of the hepatitis viruses. Gastroenterology 1993;104:955-63.
9. World Health Organization. Hepatitis C - global prevalence (update). Wkly Epidemiol Rec 1999;49:425-7.
10. Health Canada. Diseases and conditions: hepatitis. Last updated 28 July 2006 [cited 1 March 2006]; Available at: http://www.hc-sc.gc.ca/dc-ma/hep/ index_e.html
11. Daly P. Hepatitis C and the British Columbia experience with hepatitis A vaccination. J Viral Hepat 2000;7 (Suppl. 1):23-5.
12. Zou S, Tepper M, Giulivi A. Current status of hepatitis C in Canada. Can J Public Health 2000;91(Suppl. 1):S10-S15, S-6.
13. Spinelli JJ, Ng C, Weber JP, Connors J, Gascoyne RD, Lai AS, Brooks-Wilson AR, Le ND, Berry BR, Gallagher RP. Organochlorines and risk of non-Hodgkin lymphoma. Int J Cancer 2007;121:2767-75.
14. Jaffe ES, Harris NL, Stein H, Vardiman JW. World Health Organization Classification of Tumors: pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press, 2001.
15. Morton LM, Turner JJ, Cerhan JR, Linet MS, Treseler PA, Clarke CA, Jack A, Cozen W, Maynadie M, Spinelli JJ, Costantini AS, Rudiger T, et al. Proposed classification of lymphoid neoplasms for epidemiologic research from the International Lymphoma Epidemiology Consortium (InterLymph). Blood 2007;110:695-708.
16. BC Cancer Agency. Malignant lymphoma cancer management guidelines. Last updated 31 January 2007 [cited 1 March 2007]; Available at: http://www.bccancer. bc.ca/HPI/CancerManagementGuidelines/Lymphoma/HD/default.htm
17. Rothman KJ, Greenland S. Modern epidemiology, 2nd edn. Philadelphia, PA: Lippincott-Raven, 1998.
18. Begg CB, Zhang ZF. Statistical analysis of molecular epidemiology studies employing case-series. Cancer Epidemiol Biomarkers Prev 1994;3:173-5.
19. Dubin N, Pasternack BS. Risk assessment for case-control subgroups by polychotomous logistic regression. Am J Epidemiol 1986;123:1101-17.
20. Hermine O, Lefrere F, Bronowicki JP, Mariette X, Jondeau K, Eclache-Saudreau V, Delmas B, Valensi F, Cacoub P, Brechot C, Varet B, Troussard X. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 2002;347:89-94.
21. Sansonno D, De Vita S, Cornacchiulo V, Carbone A, Boiocchi M, Dammacco F. Detection and distribution of hepatitis C virus-related proteins in lymph nodes of patients with type II mixed cryoglobulinemia and neoplastic or non-neoplastic lymphoproliferation. Blood 1996;88:4638-45.
22. Sung VM, Shimodaira S, Doughty AL, Picchio GR, Can H, Yen TS, Lindsay KL, Levine AM, Lai MM. Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection. J Virol 2003;77:2134-46.
23. Zuckerman E, Zuckerman T. Hepatitis C and B-cell lymphoma: the hemato-hepatologist linkage. Blood Rev 2002;16:119-25.
24. Mazzaro C, Tirelli U, Pozzato G. Hepatitis C virus and non-Hodgkin's lymphoma 10 years later. Dig Liver Dis 2005;37:219-26.
25. De Re V, De Vita S, Marzotto A, Rupolo M, Gloghini A, Pivetta B, Gasparotto D, Carbone A, Boiocchi M. Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia. Blood 2000;96:3578-84.
26. Cacoub P, Bourliere M, Hausfater P, Charlotte F, Khiri H, Toci S, Piette JC, Poynard T, Halfon P. Lower expression of CD81 B-cell receptor in lymphoproliferative diseases associated with hepatitis C virus infection. J Viral Hepat 2003;10:10-15.
27. Zignego AL, Giannelli F, Marrocchi ME, Mazzocca A, Ferri C, Giannini C, Monti M, Caini P, Villa GL, Laffi G, Gentilini P. T(14;18) translocation in chronic hepatitis C virus infection. Hepatology 2000;31:474-9.
28. Zignego AL, Ferri C, Giannelli F, Giannini C, Caini P, Monti M, Marrocchi ME, Di Pietro E, La Villa G, Laffi G, Gentilini P. Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. Ann Intern Med 2002;137:571-80.
29. Collier JD, Zanke B, Moore M, Kessler G, Krajden M, Shepherd F, Heathcote J. No association between hepatitis C and B-cell lymphoma. Hepatology 1999;29:1259-61.
30. Shariff S, Yoshida EM, Gascoyne RD, Le N, Connors JM, Middleton PJ, Shenkier TN. Hepatitis C infection and B-cell non-Hodgkin's lymphoma in British Columbia: a cross-sectional analysis. Ann Oncol 1999;10:961-4.